Vecamyl (mecamylamine hydrochloride tablets – Tilde) — Cigna

Initial criteria

• Patient has tried four antihypertensive therapies, each from different pharmacologic classes (e.g., diuretics, calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers [as single-entity or as combination products]); AND
• For each of these agents, patient meets ONE of the following (i or ii):
• i. Patient has had inadequate efficacy; OR
• ii. Patient has experienced adverse event(s) severe enough to warrant discontinuation of this agent, according to the prescriber.

Approval duration

1 year